Substituted m-xylylene diamines for the treatment of diseases of the central nervous system
申请人:LILLY INDUSTRIES LIMITED
公开号:EP0645370A1
公开(公告)日:1995-03-29
Pharmaceutical compounds of the formula:
in which A is
B is
R¹ to R⁸ are each hydrogen or C₁₋₄ alkyl, m, n and p are each 0, 1, or 2, q is 0, 1, 2 or 3, X and Z are each C₁₋₄ alkyl, C₁₋₄ alkoxy, hydroxy, nitro, cyano, halo, trihalomethyl, carboxy, C₁₋₄ alkoxy-carbonyl or phenyl, and in addition Z, together with the phenyl ring to which it is attached, can be:
Y is -O-, -S- or -CH₂-, V is -(CH₂)r- or -(CH₂)rS- where r is 1 to 15, and W is hydrogen or optionally substituted phenyl; and salts thereof.
式中的药物化合物:
其中 A 为
B 是
R¹至R⁸各自为
氢或C₁₋₄烷基,m、n和p各自为0、1或2,q为0、1、2或3,X和Z各自为C₁₋₄烷基、C₁₋₄烷
氧基、羟基、硝基、
氰基、卤代、三卤
甲基、羧基、C₁₋₄烷
氧基-羰基、硝基、
氰基、卤代、三卤
甲基、羧基、C₁₋₄ 烷
氧羰基或
苯基,此外,Z 及其所连接的
苯基环可以是:
Y为-O-、-S-或-CH₂-,V为-(CH₂)r-或-(CH₂)rS-,其中 r 为 1 至 15,W 为
氢或任选取代的
苯基;及其盐类。